Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol
NCT00566813Phase 2Completed
- Sponsor
- University of Illinois Chicago
- Start
- Nov 2004
- Primary completion
- Jul 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of islet transplantation in type 1 diabetes mellitus (T1D) (2 arms), sponsored by University of Illinois Chicago. Primary endpoints: Number of Participants With Adverse Events Including Laboratory Abnormalities at 15 months, Number of Participants With Insulin Independence at 15 months and 1 more. Started Nov 2004; status: completed.
02
Drugs
islet transplantation
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00566813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566813.